| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |